Global Hematopoietic Stem Cell Transplantation Market: Overview
Hematopoietic stem cells (HSCs) are present in the bone marrow and blood. They are also known as hematopoietic progenitor cells (HPCs). Hematopoietic stem cells are capable of producing mature blood cells, such as platelets, white blood cells, and red blood cells. These cells are used in the treatment of different types of malignant diseases (e.g. lymphoma, leukemia) and non-malignant (e.g. hemoglobinopathies, bone marrow failure) to rebuild or replace a patient's hematopoietic system. This type of treatment is known as stem cell transplant or bone marrow transplant. Hematopoietic stem cells have also been used in clinical trials with U.S. FDA oversight for the treatment of genetic diseases, autoimmune diseases, and other indications. Over the last 30 years, the hematopoietic stem cells transplantation market has seen a rapid and constant expansion with advancements in lifesaving technologies. Hematopoietic stem cell transplantation brings about restoration of the patient’s medullary and immune function while treating a diverse range of about 70 non-hematological and hematological disorders. Overall, hematopoietic stem cells transplantation is used in the treatment of immunological, oncological, non-malignant, hematological, malignant, and hereditary diseases.
There are two types of stem cell transplants: allogeneic and autologous. Allogeneic HSCT involves the replacement of diseased or damaged cells with cells from a healthy donor. The donor’s tissue type needs to match the receiver’s tissue type as closely as possible to help prevent the risk of problems with the transplant. Allogeneic transplantation is used for therapeutic intervention of patients with hematological disorders (cancerous or non-cancerous). Autologous HSCT replaces diseased or damaged cells with the patient’s own stem cells. Harvesting of a patient’s stem cells is done before chemotherapy, and harvested stem cells are then transplanted back into the patient after treatment. Based on the source of hematopoietic stem cells, there are three types of HSCTs: cord blood transplant, peripheral blood stem cell transplant, and bone marrow transplant (BMT).
Global Hematopoietic Stem Cell Transplantation Market: Key Trends
The global hematopoietic stem cell transplantation market is expected to expand at a rapid pace, due to a rise in the prevalence of hematopoietic disorders, increase in success rates of transplantation, and increase in the aging population across the world. According to a research report by the Scientific America, transplantation rates over the globe have increased from 50,000 HSC transplants per year in 2012 to 75,000 HSC transplants per year in 2015. However, high cost of transplantation and lack of funding for organizations such as the Worldwide Network for Blood & Marrow Transplantation (WBMT) are expected to restrain the global hematopoietic stem cell transplantation market during forecast period.
Global Hematopoietic Stem Cell Transplantation Market: Segmentation
The global hematopoietic stem cell transplantation market can be segmented based on disease indication, transplant, application, and region. In terms of disease indication, the market can be classified into leukemia, lymphoproliferative disorders, and non-malignant disorders. Based on transplant, the global hematopoietic stem cell transplantation market can be categorized into autologous and allogeneic. Allogeneic transplant is projected to continue to hold a dominant market share in terms of revenue during the forecast period, due to the high average cost of allogeneic transplants as compared to that of autologous transplants. In terms of application, the market can be segmented into cord blood transplants, peripheral blood stem cells transplants, and bone marrow transplants.
Global Hematopoietic Stem Cell Transplantation Market: Regional Analysis
Based on region, the global hematopoietic stem cell transplantation market can be segmented into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. Europe is projected to lead the global market during the forecast period. The region’s dominance is attributed to the overall increase in success rate of transplants, easy technological applications, and high income of the population.
Global Hematopoietic Stem Cell Transplantation Market: Competitive Landscape
Key players operating in the global hematopoietic stem cell transplantation market include Escape Therapeutics, Lonza Group, Regen BioPharma Inc, Cesca Therapeutics Inc., Cryo-Save AG, CBR Systems, Inc., Pluristem Therapeutics Inc., China Cord Blood Corporation, and ViaCord Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.